Screening of cognitive impairment in patients with Parkinson’s disease: diagnostic validity of the Brazilian versions of the Montreal Cognitive Assessment and the Addenbrooke’s Cognitive Examination-Revised
Document title: Screening of cognitive impairment in patients with Parkinson’s disease: diagnostic validity of the Brazilian versions of the Montreal Cognitive Assessment and the Addenbrooke’s Cognitive Examination-Revised
Journal: Arquivos de neuro-psiquiatria
Database: PERIÓDICA
System number: 000404477
ISSN: 0004-282X
Authors: 1
1
1
2
1
1
3
3
3
1
Institutions: 1Universidade de Sao Paulo, Faculdade de Medicina de Ribeirao Preto, Ribeirao Preto, Sao Paulo. Brasil
2Universidade de Fortaleza, Faculdade de Medicina, Fortaleza, Ceara. Brasil
3University of Washington, School of Medicine, Seattle, Washington. Estados Unidos de América
Year:
Season: Nov
Volumen: 73
Number: 11
Pages: 929-933
Country: Brasil
Language: Inglés
Document type: Artículo
Approach: Analítico
English abstract Objective: The aim of the present study is to examine the accuracy of the Brazilian versions of the Montreal Cognitive Assessment (MoCA) and the Addenbrooke’s Cognitive Examination-Revised (ACE-R) to screen for mild cognitive impairment (PDMCI) and dementia (PDD) in patients with Parkinson`s disease (PD). Method: Both scales were administered to a final convenience sample of 79 patients with PD. Patients were evaluated by a neurologist, a psychiatrist and a neuropsychologist using UPDRS, Hoehn and Yahr and Schwab and England scales, global deterioration scale, a psychiatric structured interview, Mattis Dementia Rating Scale and other cognitive tests. Results: There were 32 patients with PDMCI and 17 patients with PDD. The MoCA and the ACE-R were able to discriminate patients with PDD from the others. Conclusion: Both scales showed to be useful to screen for dementia but not for mild cognitive impairment in patients with PD
Portuguese abstract Objetivo: O objetivo do estudo foi avaliar a acurácia das versões Brasileiras das escalas: Montreal Cognitive Assessment (MoCA) e Addenbrooke’s Cognitive Examination-Revised (ACE-R), no rastreamento de comprometimento cognitivo leve (CCL) e demência em pacientes com doença de Parkinson (DP). Método: As duas escalas foram aplicadas a uma amostra de conveniência de 79 pacientes com DP. Os pacientes foram avaliados por um neurologista, um psiquiatra e uma neuropsicóloga que utilizaram a UPDRS, a escala de Hoehn e Yahr, a escala de Schwab e England, a escala de deterioração global, uma entrevista psiquiátrica estruturada, a escala de demência de Mattis e outros testes cognitivos. Resultados: 32 pacientes foram diagnosticados com CCL e 17 com demência. A MoCA e o ACE-R foram capazes de discriminar pacientes com demência dos demais. Conclusão: As duas escalas se mostraram úteis para rastrear demência, mas não CCL, em pacientes com DP
Disciplines: Medicina,
Psicología
Keyword: Neurología,
Psiquiatría,
Psicometría,
Escalas,
Deterioro cognitivo,
Enfermedad de Parkinson
Keyword: Medicine,
Psychology,
Neurology,
Psychiatry,
Psychometrics,
Scales,
Cognitive impairment,
Parkinson disease
Full text: Texto completo (Ver PDF)